What Diabetes Clinical Trials Look Like Right Now
Across the United States, research sites are actively enrolling volunteers for studies that range from early prevention efforts to advanced technology trials. One example currently recruiting through the National Institute of Diabetes and Digestive and Kidney Diseases compares two infusion-based therapies, teplizumab and ATG, to see whether either can delay the onset of Stage 3 type 1 diabetes in people aged 4 to 34 who are already in Stage 2. That trial, listed as NCT07216391, is running at multiple academic centers including the Barbara Davis Center in Colorado and Yale University in Connecticut.
Another area generating real momentum is GLP-1 research. A Yale-led study is examining how weekly semaglutide affects cardiometabolic risk in young adults with type 1 diabetes who also carry excess weight, since more than 40 percent of this group faces that combination. Meanwhile, device companies like Insulet have been testing next-generation automated insulin delivery algorithms in adults with type 2 diabetes, with the goal of making insulin pumps smarter and more responsive to real-world eating patterns.
The Three Big Reasons People Hesitate
Despite the promise, most people never search for a trial. Three concerns come up again and again in patient conversations.
Fear of being a guinea pig. Many Americans picture sterile labs and risky experiments. In reality, every trial operating in the US follows a structured protocol reviewed by an institutional review board, and participants can withdraw at any point without losing access to their regular care.
Confusion about eligibility. Each study has its own inclusion and exclusion criteria, and the language on ClinicalTrials.gov is written for researchers, not patients. A person with well-managed type 2 diabetes may assume they do not qualify for a study that is actually looking for people just like them.
Worry about cost and logistics. Questions about who pays for the study drug, whether travel is covered, and how much time is required stop many people before they even ask.
How to Match With a Trial That Fits You
Finding the right study does not have to mean hours of scrolling through dense medical jargon. Patient-friendly matching tools, such as Antidote Match, let you enter your diabetes type, your approximate A1c, and your current medications, then generate a shortlist of trials for which you are likely to qualify. This is far more practical than browsing ClinicalTrials.gov directly, though that database remains the official record of every registered study in the country.
Once you have a shortlist, contact the study coordinator listed for each trial. Coordinators are the people who answer questions, explain the time commitment, and walk you through what happens at each visit. A useful question to ask early is whether the study covers the cost of the investigational treatment and any related testing, since most interventional trials provide the study drug at no charge to participants while they are enrolled.
What to Expect in Terms of Compensation and Time
Compensation varies widely by study type and length. Some observational studies offer modest amounts for time and travel, while interventional trials with more intensive visits may offer more substantial reimbursement. The Stanford Diabetes Research Center, for example, has listed studies where participants receive between $50 and $75 per visit for remote or on-site sessions, and other programs across the country follow similar per-visit models. Rather than focusing on a specific dollar figure, think of compensation as partial recognition of your time, not as income.
Time commitment matters just as much as payment. A prevention trial might require a screening visit followed by quarterly check-ins over a year, while a device study could ask for a two-week run-in period before you even begin using the new system. Before you sign anything, map out the visit schedule against your work and family obligations. Coordinators are usually flexible about scheduling, but they cannot reduce the number of required visits.
A Closer Look at Current Study Types
| Study Category | Example Currently Recruiting | Typical Participant Profile | What Participants Gain | Common Challenges |
|---|
| Type 1 Prevention | Teplizumab vs. ATG infusion trial (NCT07216391) | Ages 4–34, Stage 2 T1D | Access to investigational therapies aimed at delaying diagnosis | Infusion visits, multi-year follow-up |
| GLP-1 and Weight | Yale semaglutide study in T1D with obesity | Young adults 18–35, T1D plus overweight | Weekly injectable medication, body composition scans, close metabolic monitoring | Frequent testing, 12-month commitment |
| Automated Insulin Delivery | Insulet Omnipod algorithm studies | Adults 16–70 with T2D using insulin | Hands-on experience with prototype pump software | Device training, data logging expectations |
| Behavioral and Lifestyle | Stanford VITAL-CGM weight loss program | Adults 18–69 with T2D | Free Weight Watchers app, CGM access, virtual coaching | Remote self-monitoring, consistent participation |
This table is not exhaustive, but it captures the range of what is enrolling right now across US research centers.
Steps to Get Started This Week
Step 1: Know your numbers. Before reaching out to any study, gather your most recent A1c result, a list of current diabetes medications, and any other conditions you manage. Many eligibility screens start with these basics.
Step 2: Use a patient-facing search tool. Try a matching platform like Antidote Match, or search phrases such as "diabetes clinical trials near me" plus your state name. This surface-level search is where most people find their first real options.
Step 3: Verify the study record. Once you have a trial name, look it up on ClinicalTrials.gov to confirm the sponsor, the phase, and whether the site is still recruiting. A quick call to the contact listed there saves you from driving to a site that has already filled its slots.
Step 4: Prepare your questions. Ask about the placebo possibility, how often you will need to come in, whether the study covers the investigational drug, and what happens if you decide to leave early. Write the answers down so you can compare trials side by side.
Step 5: Talk with your own doctor. Your regular endocrinologist or primary care physician should review the protocol before you enroll. They can flag interactions with your current medications and help you decide whether pausing or changing any part of your routine is safe.
Regional Resources Worth Knowing
Research strength varies by region. The Barbara Davis Center in Colorado, Yale University in Connecticut, the University of Florida in Gainesville, and Stanford in California all run active diabetes research programs with dedicated coordinators who respond to public inquiries. Larger metropolitan areas like Boston, Houston, and Seattle also host academic medical centers with robust endocrinology divisions. If you live outside these hubs, ask your local clinic whether they partner with any research network, since many community practices now screen patients for trials run by nearby universities.
A Word on Safety and Oversight
Every US trial must register on ClinicalTrials.gov, and federally funded studies are reviewed by institutional review boards that weigh participant safety against the study's scientific value. You will be asked to sign an informed consent form, which is not a contract but a detailed explanation of risks, benefits, and your right to withdraw. Do not rush this step. Reading it with a family member or your doctor is a reasonable and common practice.
Participants who complete trials often describe the experience as more educational than they expected. You learn your own glucose patterns in greater detail, you meet specialists who think about diabetes all day, and you contribute to data that may help the next person diagnosed. That combination of personal insight and collective benefit is hard to find anywhere else in healthcare.
The search for better diabetes treatments depends on volunteers. If you have been curious about clinical research, start with a simple search this week, gather your A1c number, and send one email to a study coordinator. You may find that the trial is less intimidating and more rewarding than you assumed.
研究の知恵